About this trial
direct comparisons between ESPB and M-TAPA for postoperative analgesia after LC remain limited. This is an important area of clinical interest because the two blocks differ significantly in their anatomical targets, mechanism of analgesia, and likely dermatomal coverage. The ESPB provides analgesia through paravertebral spread affecting both dorsal and ventral rami, thereby offering posterior and visceral pain relief, whereas M-TAPA directly targets the thoracoabdominal nerves, resulting in better anterior and lateral abdominal wall analgesia. Understanding which technique offers superior or more balanced analgesia could help to optimise regional anaesthesia strategies in LC and to improve patient outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: between 30 - 65
American Society of Anaesthesiologists physical status: I- III
Body mass index: 18-35 kg.m-2
Disqualifiers
Patient Refusal
Allergy to local anaesthetic agents.
Skin infection at the site of injection.
Coagulopathy.
Trial design
Parallel
Treatments tested in this trial
bilateral ESP block
Other interventionbilateral ESP block with injection of 20 ml 0.25% bupivacaine.
bilateral M-TAPA block
Other interventionbilateral M-TAPA block with injection of 20 ml of 0.25% bupivacaine.
Treatment groups
Trial outcomes
Primary outcomes
Time to First Analgesic request
minutes
Secondary outcomes
Total Nalbuphine consumption
mg
Visual analogue score
0 no pain , 10 severe pain
Quality of postoperative recovery
QOR 15
Incidence of complications or adverse events
local anesthetic toxicity, bleeding
Sponsors and contacts
Click on the lead sponsor to view all of their trials.